Canada Life’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-21,480
| Closed | -$20K | – | 1838 |
|
|
2026
Q1 | $20K | Hold |
21,480
| – | – | ﹤0.01% | 1826 |
|
|
2025
Q4 | $27K | Sell |
21,480
-87,123
| -80% | -$117K | ﹤0.01% | 1839 |
|
|
2025
Q3 | $137K | Buy |
108,603
+87,123
| +406% | +$114K | ﹤0.01% | 1728 |
|
|
2025
Q2 | $26K | Hold |
21,480
| – | – | ﹤0.01% | 1882 |
|
|
2025
Q1 | $23K | Hold |
21,480
| – | – | ﹤0.01% | 1921 |
|
|
2024
Q4 | $37K | Hold |
21,480
| – | – | ﹤0.01% | 1907 |
|
|
2024
Q3 | $41K | Hold |
21,480
| – | – | ﹤0.01% | 1962 |
|
|
2024
Q2 | $38K | Hold |
21,480
| – | – | ﹤0.01% | 1990 |
|
|
2024
Q1 | $58K | Buy |
+21,480
| New | +$51.9K | ﹤0.01% | 2003 |
|
|
2022
Q2 | – | Sell |
-5,235
| Closed | -$20K | – | 2448 |
|
|
2022
Q1 | $20K | Hold |
5,235
| – | – | ﹤0.01% | 2353 |
|
|
2021
Q4 | $20K | Hold |
5,235
| – | – | ﹤0.01% | 2381 |
|
|
2021
Q3 | $35K | Hold |
5,235
| – | – | ﹤0.01% | 2323 |
|
|
2021
Q2 | $32K | Hold |
5,235
| – | – | ﹤0.01% | 2388 |
|
|
2021
Q1 | $23K | Hold |
5,235
| – | – | ﹤0.01% | 2488 |
|
|
2020
Q4 | $31K | Buy |
+5,235
| New | +$34.4K | ﹤0.01% | 2445 |
|
|
2020
Q2 | – | Sell |
-4,303
| Closed | -$11K | – | 2782 |
|
|
2020
Q1 | $11K | Hold |
4,303
| – | – | ﹤0.01% | 2494 |
|
|
2019
Q4 | $15K | Buy |
+4,303
| New | +$15.1K | ﹤0.01% | 2552 |
|
|
2019
Q3 | – | Sell |
-8,109
| Closed | -$100K | – | 1732 |
|
|
2019
Q2 | $100K | Buy |
+8,109
| New | +$103K | ﹤0.01% | 2229 |
|
|
2016
Q4 | – | Sell |
-1,788
| Closed | -$14K | – | 2536 |
|
|
2016
Q3 | $14K | Hold |
1,788
| – | – | ﹤0.01% | 2483 |
|
|
2016
Q2 | $16K | Hold |
1,788
| – | – | ﹤0.01% | 2485 |
|
|
2016
Q1 | $14K | Hold |
1,788
| – | – | ﹤0.01% | 2380 |
|
|
2015
Q4 | $19K | Hold |
1,788
| – | – | ﹤0.01% | 2369 |
|
|
2015
Q3 | $15K | Hold |
1,788
| – | – | ﹤0.01% | 2356 |
|
|
2015
Q2 | $43K | Hold |
1,788
| – | – | ﹤0.01% | 2283 |
|
|
2015
Q1 | $75K | Hold |
1,788
| – | – | ﹤0.01% | 1954 |
|
|
2014
Q4 | $60K | Hold |
1,788
| – | – | ﹤0.01% | 2024 |
|
|
2014
Q3 | $44K | Hold |
1,788
| – | – | ﹤0.01% | 2089 |
|
|
2014
Q2 | $52K | Buy |
+1,788
| New | +$57.3K | ﹤0.01% | 1933 |
|
Other funds holding LAB
CC
MCO
LFCM
HBWM
RA
Canada Life's LAB Position: Q2 2026 in Review
Canada Life sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 21,480 shares — an estimated $20K sold.
Canada Life first reported a position in LAB in Q2 2014 and held it in 28 quarters. The position peaked at $137K in Q3 2025. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.
- Canada Life reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
- Canada Life sold 21,480 Standard BioTools shares in Q2 2026, an estimated $20K.
- Canada Life first reported a position in Standard BioTools in Q2 2014 and held it in 28 quarters.
- Canada Life's Standard BioTools position peaked at $137K in Q3 2025.
- 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.
Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.